{"id":1284,"date":"2019-05-08T13:46:48","date_gmt":"2019-05-08T13:46:48","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1284"},"modified":"2026-02-24T00:39:36","modified_gmt":"2026-02-24T00:39:36","slug":"prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/","title":{"rendered":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman)"},"content":{"rendered":"<p>In this study we describe the prenatal characteristics of Noonan syndrome and its associated syndromes called Rasopathies in 40 fetuses with a pathogenic variant in one of the Rasopathy genes. The most common feature is increased nuchal translucency (NT). Based on our data we suggest genetic testing of fetuses with an isolated persistent NT \u22655.0 mm (after excluding chromosomal aberrations). We also recommend genetic testing when NT is \u22653.5 mm with at least one of the following anomalies: distended jugular lymph sacs, hydrops fetalis, polyhydramnios, pleural effusion and\/or cardiac defects. Renal anomalies and ascites were poor predictors of finding a pathogenic Rasopathy variant. No clear genotype-phenotype correlation was detected. (<a href=\"https:\/\/jmg.bmj.com\/content\/early\/2019\/04\/30\/jmedgenet-2018-105746\">https:\/\/jmg.bmj.com\/content\/early\/2019\/04\/30\/jmedgenet-2018-105746<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In this study we describe the prenatal characteristics of Noonan syndrome and its associated syndromes called Rasopathies in 40 fetuses with a pathogenic variant in one of the Rasopathy genes. The most common feature is increased nuchal translucency (NT). Based on our data we suggest genetic testing of fetuses with an isolated persistent NT \u22655.0 [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1284","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"In this study we describe the prenatal characteristics of Noonan syndrome and its associated syndromes called Rasopathies in 40 fetuses with a pathogenic variant in one of the Rasopathy genes. The most common feature is increased nuchal translucency (NT). Based on our data we suggest genetic testing of fetuses with an isolated persistent NT \u22655.0 [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-08T13:46:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:39:36+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman)\",\"datePublished\":\"2019-05-08T13:46:48+00:00\",\"dateModified\":\"2026-02-24T00:39:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/\"},\"wordCount\":137,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/\",\"name\":\"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2019-05-08T13:46:48+00:00\",\"dateModified\":\"2026-02-24T00:39:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/05\\\/08\\\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/","og_locale":"en_US","og_type":"article","og_title":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog","og_description":"In this study we describe the prenatal characteristics of Noonan syndrome and its associated syndromes called Rasopathies in 40 fetuses with a pathogenic variant in one of the Rasopathy genes. The most common feature is increased nuchal translucency (NT). Based on our data we suggest genetic testing of fetuses with an isolated persistent NT \u22655.0 [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/","og_site_name":"JMG Contact blog","article_published_time":"2019-05-08T13:46:48+00:00","article_modified_time":"2026-02-24T00:39:36+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman)","datePublished":"2019-05-08T13:46:48+00:00","dateModified":"2026-02-24T00:39:36+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/"},"wordCount":137,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/","url":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/","name":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2019-05-08T13:46:48+00:00","dateModified":"2026-02-24T00:39:36+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/05\/08\/prenatal-ultrasound-findings-of-rasopathies-in-a-cohort-of-424-fetuses-update-on-genetic-testing-in-the-ngs-era\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era (Contributed by Kyra Stuurman)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1284"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1284\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}